DoP

DoP Allocates INR 243 Cr for Establishing Centers of Excellence in NIPERs July 3, 2024 The steering committee approved CoE proposals from all National Institute of Pharmaceutical Education and Research (NIPERs) and sanctioned a budget of INR 700 Cr for the next five years.

Government to Overhaul Drug Pricing Committee Amid Industry Pushback June 27, 2024 Reportedly, the proposed changes come after numerous complaints from pharma associations about the current pricing framework.

DoP Expands Committee Responsible for Drugs & Medical Devices Pricing Reform June 25, 2024 Initially formed in March this year, the committee's scope has broadened to include representatives from major pharmacy trade organizations, healthcare service providers, and doctors' associations, as well as various patient advocacy groups. Let us know what’s the scope of work of this expansion

Health Minister JP Nadda Holds Review Meeting with DoP June 17, 2024 Minister Nadda reiterated that quality should be a key focus, ensuring all manufacturing plants meet world-class standards within the stipulated time frame.

India's Growing Dependence on Chinese Bulk Drug Imports Persists Despite Policy Efforts June 13, 2024 This growing dependency comes amid efforts by the Indian government and the pharmaceutical industry to diversify sources and reduce reliance on China.

DoP Launches New Portal to Implement R&D Policy in Pharma-Medtech Sector May 27, 2024 The ICPMR is set to lead the Drug Discovery Mission, a multi-institutional initiative that pools the strengths of various research institutions.

DoP Secy Bats for Collaboration to Ensure Medtech Growth May 9, 2024 DoP is boosting medical device export competitiveness through value-added manufacturing, targeting an import coverage ratio of 1.0.

NPPA Working on New Pricing Framework for Medical Devices April 29, 2024 Once the expert committee finalizes its recommendations, they will be forwarded to the Department of Pharmaceuticals (DoP) for further review.

Parl Panel Raises Concerns Over Regulatory Gap for Refurbished Medical Devices March 20, 2024 The Department-related Parliamentary Standing Committee on Chemicals and Fertilisers highlighted that the current laxity in regulation is compromising the standard of health services in the country.

Centre Forms Committee to Revise Drug & Medical Device Pricing Framework March 19, 2024 The committee has been specifically tasked with designing a price moderation framework for medical devices and emerging and precision therapies.

DoP Revises PLI Schemes for Bulk Drugs & Medical Devices March 15, 2024 The Department of Pharmaceuticals (DoP) has announced revision of production-linked incentive (PLI) guidelines to promote manufacturing of bulk drugs and medical devices.

AiMeD Demands Separate Pricing Policy for Medical  Devices Industry March 15, 2024 The Association of Indian Medical Devices Industry (AiMeD) has underscored the necessity for a distinct pricing mechanism and regulatory framework for the medical devices sector.